Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T00:32:07.365Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunopathogenesis of Pneumocystis carinii pneumonia

Published online by Cambridge University Press:  14 November 2005

Francis Gigliotti  and
Terry W. Wright
Francis Gigliotti
Affiliation:
University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Box 690, Rochester, NY 14642, USA.
Terry W. Wright
Affiliation:
University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Box 690, Rochester, NY 14642, USA.
Get access Rights & Permissions [Opens in a new window]

Abstract

Pneumocystis carinii pneumonia (PCP) is a life-threatening infection that occurs in immunocompromised individuals, particularly those with advanced human immunodeficiency virus (HIV) infection. Interestingly, morbidity and mortality is related to the underlying cause of immunosuppression, with AIDS patients faring better than oncology patients for example. In addition, the prognosis of PCP has been correlated with markers of inflammation rather than with organism numbers. There is now increasing evidence that lung damage occurring during PCP is a result of the type and extent of the host inflammatory response to P. carinii rather than a result of direct damage by the organism. This review will discuss the experimental and clinical data demonstrating how the host-mediated inflammatory response to infection with P. carinii determines the ultimate outcome of PCP. A better understanding of the pathophysiology of PCP should lead to the development of improved therapies for the treatment of PCP.

Keywords

Pneumocystis cariniipneumonialung injurypathogenesisinflammation
Type
Review Article
Information
Expert Reviews in Molecular Medicine , Volume 7 , Issue 26 , 15 November 2005 , pp. 1 - 16
Copyright
© Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)